Serveur d'exploration SRAS

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Nitric oxide inhibits the replication cycle of severe acute respiratory syndrome coronavirus

Identifieur interne : 000717 ( PascalFrancis/Corpus ); précédent : 000716; suivant : 000718

Nitric oxide inhibits the replication cycle of severe acute respiratory syndrome coronavirus

Auteurs : Sara Akerström ; Mehrdad Mousavi-Jazi ; Jonas Klingström ; Mikael Leijon ; Ake Lundkvist ; Ali Mirazimi

Source :

RBID : Pascal:05-0134586

Descripteurs français

English descriptors

Abstract

Nitric oxide (NO) is an important signaling molecule between cells which has been shown to have an inhibitory effect on some virus infections. The purpose of this study was to examine whether NO inhibits the replication cycle of the severe acute respiratory syndrome coronavirus (SARS CoV) in vitro. We found that an organic NO donor, S-nitroso-N-acetylpenicillamine, significantly inhibited the replication cycle of SARS CoV in a concentration-dependent manner. We also show here that NO inhibits viral protein and RNA synthesis. Furthermore, we demonstrate that NO generated by inducible nitric oxide synthase, an enzyme that produces NO, inhibits the SARS CoV replication cycle.

Notice en format standard (ISO 2709)

Pour connaître la documentation sur le format Inist Standard.

pA  
A01 01  1    @0 0022-538X
A03   1    @0 J. virol.
A05       @2 79
A06       @2 3
A08 01  1  ENG  @1 Nitric oxide inhibits the replication cycle of severe acute respiratory syndrome coronavirus
A11 01  1    @1 AKERSTRÖM (Sara)
A11 02  1    @1 MOUSAVI-JAZI (Mehrdad)
A11 03  1    @1 KLINGSTRÖM (Jonas)
A11 04  1    @1 LEIJON (Mikael)
A11 05  1    @1 LUNDKVIST (Ake)
A11 06  1    @1 MIRAZIMI (Ali)
A14 01      @1 Center for Microbiological Preparedness, Swedish Institute for Infectious Disease Control @2 Solna @3 SWE @Z 1 aut. @Z 3 aut. @Z 5 aut. @Z 6 aut.
A14 02      @1 LightUp Technologies @2 Huddinge @3 SWE @Z 2 aut. @Z 4 aut.
A14 03      @1 MTC/Karolinska Institutet @2 Stockholm @3 SWE @Z 3 aut. @Z 5 aut.
A20       @1 1966-1969
A21       @1 2005
A23 01      @0 ENG
A43 01      @1 INIST @2 13592 @5 354000127060900660
A44       @0 0000 @1 © 2005 INIST-CNRS. All rights reserved.
A45       @0 34 ref.
A47 01  1    @0 05-0134586
A60       @1 P
A61       @0 A
A64 01  1    @0 Journal of virology
A66 01      @0 USA
C01 01    ENG  @0 Nitric oxide (NO) is an important signaling molecule between cells which has been shown to have an inhibitory effect on some virus infections. The purpose of this study was to examine whether NO inhibits the replication cycle of the severe acute respiratory syndrome coronavirus (SARS CoV) in vitro. We found that an organic NO donor, S-nitroso-N-acetylpenicillamine, significantly inhibited the replication cycle of SARS CoV in a concentration-dependent manner. We also show here that NO inhibits viral protein and RNA synthesis. Furthermore, we demonstrate that NO generated by inducible nitric oxide synthase, an enzyme that produces NO, inhibits the SARS CoV replication cycle.
C02 01  X    @0 002A05C10
C03 01  X  FRE  @0 Coronavirus @2 NW @5 01
C03 01  X  ENG  @0 Coronavirus @2 NW @5 01
C03 01  X  SPA  @0 Coronavirus @2 NW @5 01
C03 02  X  FRE  @0 Azote monoxyde @2 NK @2 FX @5 05
C03 02  X  ENG  @0 Nitric oxide @2 NK @2 FX @5 05
C03 02  X  SPA  @0 Nitrógeno monóxido @2 NK @2 FX @5 05
C03 03  X  FRE  @0 Réplication @5 06
C03 03  X  ENG  @0 Replication @5 06
C03 03  X  SPA  @0 Replicación @5 06
C03 04  X  FRE  @0 Microbiologie @5 07
C03 04  X  ENG  @0 Microbiology @5 07
C03 04  X  SPA  @0 Microbiología @5 07
C03 05  X  FRE  @0 Virologie @5 08
C03 05  X  ENG  @0 Virology @5 08
C03 05  X  SPA  @0 Virología @5 08
C03 06  X  FRE  @0 Syndrome respiratoire aigu sévère @2 NM @5 14
C03 06  X  ENG  @0 Severe acute respiratory syndrome @2 NM @5 14
C03 06  X  SPA  @0 Síndrome respiratorio agudo severo @2 NM @5 14
C07 01  X  FRE  @0 Coronaviridae @2 NW
C07 01  X  ENG  @0 Coronaviridae @2 NW
C07 01  X  SPA  @0 Coronaviridae @2 NW
C07 02  X  FRE  @0 Nidovirales @2 NW
C07 02  X  ENG  @0 Nidovirales @2 NW
C07 02  X  SPA  @0 Nidovirales @2 NW
C07 03  X  FRE  @0 Virus @2 NW
C07 03  X  ENG  @0 Virus @2 NW
C07 03  X  SPA  @0 Virus @2 NW
C07 04  X  FRE  @0 Appareil respiratoire pathologie @5 13
C07 04  X  ENG  @0 Respiratory disease @5 13
C07 04  X  SPA  @0 Aparato respiratorio patología @5 13
C07 05  X  FRE  @0 Virose
C07 05  X  ENG  @0 Viral disease
C07 05  X  SPA  @0 Virosis
C07 06  X  FRE  @0 Infection
C07 06  X  ENG  @0 Infection
C07 06  X  SPA  @0 Infección
C07 07  X  FRE  @0 Poumon pathologie @5 16
C07 07  X  ENG  @0 Lung disease @5 16
C07 07  X  SPA  @0 Pulmón patología @5 16
N21       @1 087
N44 01      @1 OTO
N82       @1 OTO

Format Inist (serveur)

NO : PASCAL 05-0134586 INIST
ET : Nitric oxide inhibits the replication cycle of severe acute respiratory syndrome coronavirus
AU : AKERSTRÖM (Sara); MOUSAVI-JAZI (Mehrdad); KLINGSTRÖM (Jonas); LEIJON (Mikael); LUNDKVIST (Ake); MIRAZIMI (Ali)
AF : Center for Microbiological Preparedness, Swedish Institute for Infectious Disease Control/Solna/Suède (1 aut., 3 aut., 5 aut., 6 aut.); LightUp Technologies/Huddinge/Suède (2 aut., 4 aut.); MTC/Karolinska Institutet/Stockholm/Suède (3 aut., 5 aut.)
DT : Publication en série; Niveau analytique
SO : Journal of virology; ISSN 0022-538X; Etats-Unis; Da. 2005; Vol. 79; No. 3; Pp. 1966-1969; Bibl. 34 ref.
LA : Anglais
EA : Nitric oxide (NO) is an important signaling molecule between cells which has been shown to have an inhibitory effect on some virus infections. The purpose of this study was to examine whether NO inhibits the replication cycle of the severe acute respiratory syndrome coronavirus (SARS CoV) in vitro. We found that an organic NO donor, S-nitroso-N-acetylpenicillamine, significantly inhibited the replication cycle of SARS CoV in a concentration-dependent manner. We also show here that NO inhibits viral protein and RNA synthesis. Furthermore, we demonstrate that NO generated by inducible nitric oxide synthase, an enzyme that produces NO, inhibits the SARS CoV replication cycle.
CC : 002A05C10
FD : Coronavirus; Azote monoxyde; Réplication; Microbiologie; Virologie; Syndrome respiratoire aigu sévère
FG : Coronaviridae; Nidovirales; Virus; Appareil respiratoire pathologie; Virose; Infection; Poumon pathologie
ED : Coronavirus; Nitric oxide; Replication; Microbiology; Virology; Severe acute respiratory syndrome
EG : Coronaviridae; Nidovirales; Virus; Respiratory disease; Viral disease; Infection; Lung disease
SD : Coronavirus; Nitrógeno monóxido; Replicación; Microbiología; Virología; Síndrome respiratorio agudo severo
LO : INIST-13592.354000127060900660
ID : 05-0134586

Links to Exploration step

Pascal:05-0134586

Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en" level="a">Nitric oxide inhibits the replication cycle of severe acute respiratory syndrome coronavirus</title>
<author>
<name sortKey="Akerstrom, Sara" sort="Akerstrom, Sara" uniqKey="Akerstrom S" first="Sara" last="Akerström">Sara Akerström</name>
<affiliation>
<inist:fA14 i1="01">
<s1>Center for Microbiological Preparedness, Swedish Institute for Infectious Disease Control</s1>
<s2>Solna</s2>
<s3>SWE</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Mousavi Jazi, Mehrdad" sort="Mousavi Jazi, Mehrdad" uniqKey="Mousavi Jazi M" first="Mehrdad" last="Mousavi-Jazi">Mehrdad Mousavi-Jazi</name>
<affiliation>
<inist:fA14 i1="02">
<s1>LightUp Technologies</s1>
<s2>Huddinge</s2>
<s3>SWE</s3>
<sZ>2 aut.</sZ>
<sZ>4 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Klingstrom, Jonas" sort="Klingstrom, Jonas" uniqKey="Klingstrom J" first="Jonas" last="Klingström">Jonas Klingström</name>
<affiliation>
<inist:fA14 i1="01">
<s1>Center for Microbiological Preparedness, Swedish Institute for Infectious Disease Control</s1>
<s2>Solna</s2>
<s3>SWE</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
</affiliation>
<affiliation>
<inist:fA14 i1="03">
<s1>MTC/Karolinska Institutet</s1>
<s2>Stockholm</s2>
<s3>SWE</s3>
<sZ>3 aut.</sZ>
<sZ>5 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Leijon, Mikael" sort="Leijon, Mikael" uniqKey="Leijon M" first="Mikael" last="Leijon">Mikael Leijon</name>
<affiliation>
<inist:fA14 i1="02">
<s1>LightUp Technologies</s1>
<s2>Huddinge</s2>
<s3>SWE</s3>
<sZ>2 aut.</sZ>
<sZ>4 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Lundkvist, Ake" sort="Lundkvist, Ake" uniqKey="Lundkvist A" first="Ake" last="Lundkvist">Ake Lundkvist</name>
<affiliation>
<inist:fA14 i1="01">
<s1>Center for Microbiological Preparedness, Swedish Institute for Infectious Disease Control</s1>
<s2>Solna</s2>
<s3>SWE</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
</affiliation>
<affiliation>
<inist:fA14 i1="03">
<s1>MTC/Karolinska Institutet</s1>
<s2>Stockholm</s2>
<s3>SWE</s3>
<sZ>3 aut.</sZ>
<sZ>5 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Mirazimi, Ali" sort="Mirazimi, Ali" uniqKey="Mirazimi A" first="Ali" last="Mirazimi">Ali Mirazimi</name>
<affiliation>
<inist:fA14 i1="01">
<s1>Center for Microbiological Preparedness, Swedish Institute for Infectious Disease Control</s1>
<s2>Solna</s2>
<s3>SWE</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">INIST</idno>
<idno type="inist">05-0134586</idno>
<date when="2005">2005</date>
<idno type="stanalyst">PASCAL 05-0134586 INIST</idno>
<idno type="RBID">Pascal:05-0134586</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">000717</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en" level="a">Nitric oxide inhibits the replication cycle of severe acute respiratory syndrome coronavirus</title>
<author>
<name sortKey="Akerstrom, Sara" sort="Akerstrom, Sara" uniqKey="Akerstrom S" first="Sara" last="Akerström">Sara Akerström</name>
<affiliation>
<inist:fA14 i1="01">
<s1>Center for Microbiological Preparedness, Swedish Institute for Infectious Disease Control</s1>
<s2>Solna</s2>
<s3>SWE</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Mousavi Jazi, Mehrdad" sort="Mousavi Jazi, Mehrdad" uniqKey="Mousavi Jazi M" first="Mehrdad" last="Mousavi-Jazi">Mehrdad Mousavi-Jazi</name>
<affiliation>
<inist:fA14 i1="02">
<s1>LightUp Technologies</s1>
<s2>Huddinge</s2>
<s3>SWE</s3>
<sZ>2 aut.</sZ>
<sZ>4 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Klingstrom, Jonas" sort="Klingstrom, Jonas" uniqKey="Klingstrom J" first="Jonas" last="Klingström">Jonas Klingström</name>
<affiliation>
<inist:fA14 i1="01">
<s1>Center for Microbiological Preparedness, Swedish Institute for Infectious Disease Control</s1>
<s2>Solna</s2>
<s3>SWE</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
</affiliation>
<affiliation>
<inist:fA14 i1="03">
<s1>MTC/Karolinska Institutet</s1>
<s2>Stockholm</s2>
<s3>SWE</s3>
<sZ>3 aut.</sZ>
<sZ>5 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Leijon, Mikael" sort="Leijon, Mikael" uniqKey="Leijon M" first="Mikael" last="Leijon">Mikael Leijon</name>
<affiliation>
<inist:fA14 i1="02">
<s1>LightUp Technologies</s1>
<s2>Huddinge</s2>
<s3>SWE</s3>
<sZ>2 aut.</sZ>
<sZ>4 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Lundkvist, Ake" sort="Lundkvist, Ake" uniqKey="Lundkvist A" first="Ake" last="Lundkvist">Ake Lundkvist</name>
<affiliation>
<inist:fA14 i1="01">
<s1>Center for Microbiological Preparedness, Swedish Institute for Infectious Disease Control</s1>
<s2>Solna</s2>
<s3>SWE</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
</affiliation>
<affiliation>
<inist:fA14 i1="03">
<s1>MTC/Karolinska Institutet</s1>
<s2>Stockholm</s2>
<s3>SWE</s3>
<sZ>3 aut.</sZ>
<sZ>5 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Mirazimi, Ali" sort="Mirazimi, Ali" uniqKey="Mirazimi A" first="Ali" last="Mirazimi">Ali Mirazimi</name>
<affiliation>
<inist:fA14 i1="01">
<s1>Center for Microbiological Preparedness, Swedish Institute for Infectious Disease Control</s1>
<s2>Solna</s2>
<s3>SWE</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
</analytic>
<series>
<title level="j" type="main">Journal of virology</title>
<title level="j" type="abbreviated">J. virol.</title>
<idno type="ISSN">0022-538X</idno>
<imprint>
<date when="2005">2005</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt>
<title level="j" type="main">Journal of virology</title>
<title level="j" type="abbreviated">J. virol.</title>
<idno type="ISSN">0022-538X</idno>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Coronavirus</term>
<term>Microbiology</term>
<term>Nitric oxide</term>
<term>Replication</term>
<term>Severe acute respiratory syndrome</term>
<term>Virology</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr">
<term>Coronavirus</term>
<term>Azote monoxyde</term>
<term>Réplication</term>
<term>Microbiologie</term>
<term>Virologie</term>
<term>Syndrome respiratoire aigu sévère</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Nitric oxide (NO) is an important signaling molecule between cells which has been shown to have an inhibitory effect on some virus infections. The purpose of this study was to examine whether NO inhibits the replication cycle of the severe acute respiratory syndrome coronavirus (SARS CoV) in vitro. We found that an organic NO donor, S-nitroso-N-acetylpenicillamine, significantly inhibited the replication cycle of SARS CoV in a concentration-dependent manner. We also show here that NO inhibits viral protein and RNA synthesis. Furthermore, we demonstrate that NO generated by inducible nitric oxide synthase, an enzyme that produces NO, inhibits the SARS CoV replication cycle.</div>
</front>
</TEI>
<inist>
<standard h6="B">
<pA>
<fA01 i1="01" i2="1">
<s0>0022-538X</s0>
</fA01>
<fA03 i2="1">
<s0>J. virol.</s0>
</fA03>
<fA05>
<s2>79</s2>
</fA05>
<fA06>
<s2>3</s2>
</fA06>
<fA08 i1="01" i2="1" l="ENG">
<s1>Nitric oxide inhibits the replication cycle of severe acute respiratory syndrome coronavirus</s1>
</fA08>
<fA11 i1="01" i2="1">
<s1>AKERSTRÖM (Sara)</s1>
</fA11>
<fA11 i1="02" i2="1">
<s1>MOUSAVI-JAZI (Mehrdad)</s1>
</fA11>
<fA11 i1="03" i2="1">
<s1>KLINGSTRÖM (Jonas)</s1>
</fA11>
<fA11 i1="04" i2="1">
<s1>LEIJON (Mikael)</s1>
</fA11>
<fA11 i1="05" i2="1">
<s1>LUNDKVIST (Ake)</s1>
</fA11>
<fA11 i1="06" i2="1">
<s1>MIRAZIMI (Ali)</s1>
</fA11>
<fA14 i1="01">
<s1>Center for Microbiological Preparedness, Swedish Institute for Infectious Disease Control</s1>
<s2>Solna</s2>
<s3>SWE</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
</fA14>
<fA14 i1="02">
<s1>LightUp Technologies</s1>
<s2>Huddinge</s2>
<s3>SWE</s3>
<sZ>2 aut.</sZ>
<sZ>4 aut.</sZ>
</fA14>
<fA14 i1="03">
<s1>MTC/Karolinska Institutet</s1>
<s2>Stockholm</s2>
<s3>SWE</s3>
<sZ>3 aut.</sZ>
<sZ>5 aut.</sZ>
</fA14>
<fA20>
<s1>1966-1969</s1>
</fA20>
<fA21>
<s1>2005</s1>
</fA21>
<fA23 i1="01">
<s0>ENG</s0>
</fA23>
<fA43 i1="01">
<s1>INIST</s1>
<s2>13592</s2>
<s5>354000127060900660</s5>
</fA43>
<fA44>
<s0>0000</s0>
<s1>© 2005 INIST-CNRS. All rights reserved.</s1>
</fA44>
<fA45>
<s0>34 ref.</s0>
</fA45>
<fA47 i1="01" i2="1">
<s0>05-0134586</s0>
</fA47>
<fA60>
<s1>P</s1>
</fA60>
<fA61>
<s0>A</s0>
</fA61>
<fA64 i1="01" i2="1">
<s0>Journal of virology</s0>
</fA64>
<fA66 i1="01">
<s0>USA</s0>
</fA66>
<fC01 i1="01" l="ENG">
<s0>Nitric oxide (NO) is an important signaling molecule between cells which has been shown to have an inhibitory effect on some virus infections. The purpose of this study was to examine whether NO inhibits the replication cycle of the severe acute respiratory syndrome coronavirus (SARS CoV) in vitro. We found that an organic NO donor, S-nitroso-N-acetylpenicillamine, significantly inhibited the replication cycle of SARS CoV in a concentration-dependent manner. We also show here that NO inhibits viral protein and RNA synthesis. Furthermore, we demonstrate that NO generated by inducible nitric oxide synthase, an enzyme that produces NO, inhibits the SARS CoV replication cycle.</s0>
</fC01>
<fC02 i1="01" i2="X">
<s0>002A05C10</s0>
</fC02>
<fC03 i1="01" i2="X" l="FRE">
<s0>Coronavirus</s0>
<s2>NW</s2>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="ENG">
<s0>Coronavirus</s0>
<s2>NW</s2>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="SPA">
<s0>Coronavirus</s0>
<s2>NW</s2>
<s5>01</s5>
</fC03>
<fC03 i1="02" i2="X" l="FRE">
<s0>Azote monoxyde</s0>
<s2>NK</s2>
<s2>FX</s2>
<s5>05</s5>
</fC03>
<fC03 i1="02" i2="X" l="ENG">
<s0>Nitric oxide</s0>
<s2>NK</s2>
<s2>FX</s2>
<s5>05</s5>
</fC03>
<fC03 i1="02" i2="X" l="SPA">
<s0>Nitrógeno monóxido</s0>
<s2>NK</s2>
<s2>FX</s2>
<s5>05</s5>
</fC03>
<fC03 i1="03" i2="X" l="FRE">
<s0>Réplication</s0>
<s5>06</s5>
</fC03>
<fC03 i1="03" i2="X" l="ENG">
<s0>Replication</s0>
<s5>06</s5>
</fC03>
<fC03 i1="03" i2="X" l="SPA">
<s0>Replicación</s0>
<s5>06</s5>
</fC03>
<fC03 i1="04" i2="X" l="FRE">
<s0>Microbiologie</s0>
<s5>07</s5>
</fC03>
<fC03 i1="04" i2="X" l="ENG">
<s0>Microbiology</s0>
<s5>07</s5>
</fC03>
<fC03 i1="04" i2="X" l="SPA">
<s0>Microbiología</s0>
<s5>07</s5>
</fC03>
<fC03 i1="05" i2="X" l="FRE">
<s0>Virologie</s0>
<s5>08</s5>
</fC03>
<fC03 i1="05" i2="X" l="ENG">
<s0>Virology</s0>
<s5>08</s5>
</fC03>
<fC03 i1="05" i2="X" l="SPA">
<s0>Virología</s0>
<s5>08</s5>
</fC03>
<fC03 i1="06" i2="X" l="FRE">
<s0>Syndrome respiratoire aigu sévère</s0>
<s2>NM</s2>
<s5>14</s5>
</fC03>
<fC03 i1="06" i2="X" l="ENG">
<s0>Severe acute respiratory syndrome</s0>
<s2>NM</s2>
<s5>14</s5>
</fC03>
<fC03 i1="06" i2="X" l="SPA">
<s0>Síndrome respiratorio agudo severo</s0>
<s2>NM</s2>
<s5>14</s5>
</fC03>
<fC07 i1="01" i2="X" l="FRE">
<s0>Coronaviridae</s0>
<s2>NW</s2>
</fC07>
<fC07 i1="01" i2="X" l="ENG">
<s0>Coronaviridae</s0>
<s2>NW</s2>
</fC07>
<fC07 i1="01" i2="X" l="SPA">
<s0>Coronaviridae</s0>
<s2>NW</s2>
</fC07>
<fC07 i1="02" i2="X" l="FRE">
<s0>Nidovirales</s0>
<s2>NW</s2>
</fC07>
<fC07 i1="02" i2="X" l="ENG">
<s0>Nidovirales</s0>
<s2>NW</s2>
</fC07>
<fC07 i1="02" i2="X" l="SPA">
<s0>Nidovirales</s0>
<s2>NW</s2>
</fC07>
<fC07 i1="03" i2="X" l="FRE">
<s0>Virus</s0>
<s2>NW</s2>
</fC07>
<fC07 i1="03" i2="X" l="ENG">
<s0>Virus</s0>
<s2>NW</s2>
</fC07>
<fC07 i1="03" i2="X" l="SPA">
<s0>Virus</s0>
<s2>NW</s2>
</fC07>
<fC07 i1="04" i2="X" l="FRE">
<s0>Appareil respiratoire pathologie</s0>
<s5>13</s5>
</fC07>
<fC07 i1="04" i2="X" l="ENG">
<s0>Respiratory disease</s0>
<s5>13</s5>
</fC07>
<fC07 i1="04" i2="X" l="SPA">
<s0>Aparato respiratorio patología</s0>
<s5>13</s5>
</fC07>
<fC07 i1="05" i2="X" l="FRE">
<s0>Virose</s0>
</fC07>
<fC07 i1="05" i2="X" l="ENG">
<s0>Viral disease</s0>
</fC07>
<fC07 i1="05" i2="X" l="SPA">
<s0>Virosis</s0>
</fC07>
<fC07 i1="06" i2="X" l="FRE">
<s0>Infection</s0>
</fC07>
<fC07 i1="06" i2="X" l="ENG">
<s0>Infection</s0>
</fC07>
<fC07 i1="06" i2="X" l="SPA">
<s0>Infección</s0>
</fC07>
<fC07 i1="07" i2="X" l="FRE">
<s0>Poumon pathologie</s0>
<s5>16</s5>
</fC07>
<fC07 i1="07" i2="X" l="ENG">
<s0>Lung disease</s0>
<s5>16</s5>
</fC07>
<fC07 i1="07" i2="X" l="SPA">
<s0>Pulmón patología</s0>
<s5>16</s5>
</fC07>
<fN21>
<s1>087</s1>
</fN21>
<fN44 i1="01">
<s1>OTO</s1>
</fN44>
<fN82>
<s1>OTO</s1>
</fN82>
</pA>
</standard>
<server>
<NO>PASCAL 05-0134586 INIST</NO>
<ET>Nitric oxide inhibits the replication cycle of severe acute respiratory syndrome coronavirus</ET>
<AU>AKERSTRÖM (Sara); MOUSAVI-JAZI (Mehrdad); KLINGSTRÖM (Jonas); LEIJON (Mikael); LUNDKVIST (Ake); MIRAZIMI (Ali)</AU>
<AF>Center for Microbiological Preparedness, Swedish Institute for Infectious Disease Control/Solna/Suède (1 aut., 3 aut., 5 aut., 6 aut.); LightUp Technologies/Huddinge/Suède (2 aut., 4 aut.); MTC/Karolinska Institutet/Stockholm/Suède (3 aut., 5 aut.)</AF>
<DT>Publication en série; Niveau analytique</DT>
<SO>Journal of virology; ISSN 0022-538X; Etats-Unis; Da. 2005; Vol. 79; No. 3; Pp. 1966-1969; Bibl. 34 ref.</SO>
<LA>Anglais</LA>
<EA>Nitric oxide (NO) is an important signaling molecule between cells which has been shown to have an inhibitory effect on some virus infections. The purpose of this study was to examine whether NO inhibits the replication cycle of the severe acute respiratory syndrome coronavirus (SARS CoV) in vitro. We found that an organic NO donor, S-nitroso-N-acetylpenicillamine, significantly inhibited the replication cycle of SARS CoV in a concentration-dependent manner. We also show here that NO inhibits viral protein and RNA synthesis. Furthermore, we demonstrate that NO generated by inducible nitric oxide synthase, an enzyme that produces NO, inhibits the SARS CoV replication cycle.</EA>
<CC>002A05C10</CC>
<FD>Coronavirus; Azote monoxyde; Réplication; Microbiologie; Virologie; Syndrome respiratoire aigu sévère</FD>
<FG>Coronaviridae; Nidovirales; Virus; Appareil respiratoire pathologie; Virose; Infection; Poumon pathologie</FG>
<ED>Coronavirus; Nitric oxide; Replication; Microbiology; Virology; Severe acute respiratory syndrome</ED>
<EG>Coronaviridae; Nidovirales; Virus; Respiratory disease; Viral disease; Infection; Lung disease</EG>
<SD>Coronavirus; Nitrógeno monóxido; Replicación; Microbiología; Virología; Síndrome respiratorio agudo severo</SD>
<LO>INIST-13592.354000127060900660</LO>
<ID>05-0134586</ID>
</server>
</inist>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/SrasV1/Data/PascalFrancis/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000717 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/PascalFrancis/Corpus/biblio.hfd -nk 000717 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    SrasV1
   |flux=    PascalFrancis
   |étape=   Corpus
   |type=    RBID
   |clé=     Pascal:05-0134586
   |texte=   Nitric oxide inhibits the replication cycle of severe acute respiratory syndrome coronavirus
}}

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Tue Apr 28 14:49:16 2020. Site generation: Sat Mar 27 22:06:49 2021